INTERNATIONAL PATENT: KUMQUAT BIOSCIENCES INC. FILES APPLICATION FOR "USE OF SOS1 INHIBITORS AND AMIVANTAMAB TO TREAT CANCER"

GENEVA, May 6 -- KUMQUAT BIOSCIENCES INC. (10770 Wateridge Circle, Suite 120San Diego, California 92121) filed a patent application (PCT/US2024/052876) for "USE OF SOS1 INHIBITORS AND AMIVANTAMAB TO TREAT CANCER" on Oct 24, 2024. With publication no. WO/2025/090810, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIU, Yi (10770 Wateridge Circle, Suite 120San Diego, California 92121), JANES, Matthew R. (10770 Wateridge Circle, Suite 120San Diego, California 92121), HANSEN, Rasmus (10770 Wateridge Circle, Suite 120San Diego...